In the complex world of pharmaceutical manufacturing, the precise structure of molecules is paramount. This is where chiral intermediates, such as Ethyl (R)-(+)-4-Chloro-3-Hydroxybutyrate, play an indispensable role. NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical importance of these building blocks in creating drugs that are not only effective but also safe for patients. The demand for enantiomerically pure compounds has surged as researchers understand that different stereoisomers of a drug can have vastly different biological activities, ranging from therapeutic benefits to severe adverse effects.

Ethyl (R)-(+)-4-Chloro-3-Hydroxybutyrate, with its CAS number 90866-33-4, is a prime example of such a crucial chiral intermediate. Its specific stereochemistry makes it an ideal starting material or intermediate in asymmetric synthesis, a field dedicated to producing specific enantiomers. This process is fundamental in modern drug discovery and development. By utilizing high-quality chiral building blocks from reliable suppliers like NINGBO INNO PHARMCHEM CO.,LTD., pharmaceutical companies can streamline their synthesis pathways, reduce the risk of producing inactive or harmful isomers, and ultimately accelerate the journey from laboratory to market.

The application of chiral intermediates extends beyond just pharmaceutical synthesis. They are also instrumental in biochemical research, where understanding the precise molecular interactions is key. Furthermore, advancements in food additives and agricultural chemistry are increasingly relying on stereospecific compounds to achieve desired functionalities and safety profiles. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing the chemical industry with the high-purity intermediates necessary to drive innovation across these diverse sectors. We understand that the buy/purchase of these critical materials is a significant decision, and we aim to be a trusted partner, offering competitive pricing and mature technical support to ensure your research and production goals are met.